99 related articles for article (PubMed ID: 2852632)
1. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
[No Abstract] [Full Text] [Related]
2. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
3. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
4. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
5. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
[TBL] [Abstract][Full Text] [Related]
6. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
Hutchinson WL; Johnson PJ; Du MQ; Williams R
Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
[TBL] [Abstract][Full Text] [Related]
7. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
[TBL] [Abstract][Full Text] [Related]
9. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum GPDA-F determined by immunoelectrophoresis in diagnosis of hepatocellular carcinoma].
Liu HD; Ni RZ; Xiao MB; Li LR; Hua GP; Kuai XL
Ai Zheng; 2006 Feb; 25(2):247-9. PubMed ID: 16480596
[TBL] [Abstract][Full Text] [Related]
11. Fucosyltransferases: differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis.
Hutchinson WL; Du MQ; Johnson PJ; Williams R
Hepatology; 1991 Apr; 13(4):683-8. PubMed ID: 1849114
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of type III procollagen peptide in sera of patients with liver cancer].
Yamauchi M; Nakayama H; Fukuzawa K; Nakajima H; Takahara M; Nakahara M; Kawase H; Watanabe Y; Kimura K; Kitahara T
Gan No Rinsho; 1984 Jun; 30(7):785-90. PubMed ID: 6086978
[TBL] [Abstract][Full Text] [Related]
13. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
Bolarin D; Andy JJ; Alabi ZO
Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of serum alpha-L-fucosidase in primary hepatic carcinoma].
Ke JL
Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):153-5. PubMed ID: 2776057
[No Abstract] [Full Text] [Related]
15. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma.
Leray G; Deugnier Y; Jouanolle AM; Lehry D; Bretagne JF; Campion JP; Brissot P; Le Treut A
Hepatology; 1989 Feb; 9(2):249-52. PubMed ID: 2536349
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
Yu ZW; Duan FL; Yang XW
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
[TBL] [Abstract][Full Text] [Related]
17. The relationship between hepatitis-associated antigen and the development of hepatocellular cancer.
Theodoropoulos G; Economopoulos P; Mitakos S; Angelopoulos Ba
Acta Hepatogastroenterol (Stuttg); 1974 Dec; 21(6):430-2. PubMed ID: 4377058
[No Abstract] [Full Text] [Related]
18. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
Giardina MG; Matarazzo M; Varriale A; Morante R; Napoli A; Martino R
Cancer; 1992 Sep; 70(5):1044-8. PubMed ID: 1381268
[TBL] [Abstract][Full Text] [Related]
20. Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man.
Glazer RI; Vogel CL; Patel IR; Anthony PP
Cancer Res; 1974 Nov; 34(11):2975-8. PubMed ID: 4370643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
